Correlation between DXA and laboratory parameters in normal weight, overweight, and obese patients

Nutrition. 2019 May:61:143-150. doi: 10.1016/j.nut.2018.10.023. Epub 2018 Oct 24.

Abstract

Objective: The aim of this study was to review the existence and types of correlations between body composition densitometric parameters and laboratory values associated to cardiometabolic risk.

Methods: We retrospectively analyzed data from 316 individuals in the weight range from normality to super-obesity, submitted to total body dual-energy x-ray absorptiometry (DXA) scans and routine biochemistry at S.Orsola-Malpighi Hospital from June 2010 to March 2014. The study included 182 women, 45.8 ± 13.4 y of age, with a body mass index (BMI) of 31.5 (± 11) kg/m2 (group F) and 134 men, 45.4 ± 13.6 y of age, with a BMI of 27.6 (± 7.8) kg/m2 (group M). All patients underwent whole-body scan (Lunar iDXA, GE Healthcare, Madison, WI, USA) and laboratory analysis (blood fasting glucose, total cholesterol, high-density lipoprotein cholesterol, tricylglycerides [TGs], aspartate aminotransferase, and alanine aminotransferase). Correlation between laboratory values and total body and regional fat mass (including visceral adipose tissue [VAT] and subcutaneous adipose tissue in the android region), and lean mass parameters were analyzed with linear and stepwise regressions analysis (significance limit, P < 0.05). Receiver operating characteristic curves were performed to assess the accuracy of the best-fit DXA parameter (VAT) to identify at least one laboratory risk factor.

Results: In both groups, BMI and densitometric parameters showed a linear correlation with fasting blood glucose and TG levels and an inverse correlation with high-density lipoprotein cholesterol (P < 0.05), whereas no correlation was observed with total cholesterol levels. The only densitometric parameter retained in the final model of stepwise multiple regression was VAT for fasting blood glucose (group F: β = 0.4627, P < 0.0001; group M: β = 0.6221, P < 0.0001) and TG levels (group F: β = 0.4931, P < 0.0001; group M: β = 0.1990, P < 0.0261) independently of BMI. The optimal cutoff points of VAT to identify the presence of at least one laboratory risk factor were >1395 g and >1479 cm3 for men and >1281 g and >1357 cm3 for women.

Conclusions: DXA analysis of VAT is associated with selected laboratory parameters used for the evaluation of cardiometabolic risk and could be per se a helpful parameter in the assessment of clinical risk.

Keywords: Absorptiometry, Photon; Body composition; Cardiometabolic risk; Obesity; Visceral fat.

Publication types

  • Evaluation Study

MeSH terms

  • Absorptiometry, Photon / statistics & numerical data*
  • Adult
  • Alanine Transaminase
  • Aspartate Aminotransferases
  • Blood Glucose / analysis
  • Body Composition
  • Body Mass Index
  • Cardiovascular Diseases / etiology
  • Cholesterol / blood
  • Fasting / blood*
  • Female
  • Humans
  • Ideal Body Weight*
  • Intra-Abdominal Fat
  • Lipoproteins / blood
  • Male
  • Metabolic Diseases / etiology
  • Middle Aged
  • Obesity / complications
  • Obesity / physiopathology*
  • Overweight / complications
  • Overweight / physiopathology*
  • ROC Curve
  • Regression Analysis
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Subcutaneous Fat

Substances

  • Blood Glucose
  • Lipoproteins
  • Cholesterol
  • Aspartate Aminotransferases
  • Alanine Transaminase